ArticleBioinformatics (Oxford, England)2026
MethyNano: supervised contrastive pretraining enables robust and generalizable methylation detection from nanopore sequencing.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
motivation5-Methylcytosine (5mC) plays an important role in gene regulation and development. Although nanopore sequencing has enabled direct detection of 5mC, existing methods still face several limitations, including poor generalization across species and sequence contexts (CpG/CHG/CHH), as well as suboptimal integration of sequence and current signals.
resultsHere, we present MethyNano, a deep learning framework incorporating a contrastive learning strategy to detect 5mC from nanopore reads. By encouraging more discriminative and stable representations, the contrastive objective improves the model's sensitivity to rare sequence contexts and reduces its prediction uncertainty in challenging regions. Across datasets from Arabidopsis thaliana, Oryza sativa, and Homo sapiens, our model achieves superior performance on key metrics compared with other existing methods. Extensive cross-species and cross-motif experiments demonstrate the robust generalization performance of MethyNano, while dimensionality-reduction visualizations of learned features provide an intuitive view of the model's efficient representation capability. Moreover, our ablation studies show that MethyNano's architecture enables more effective integration of critical features, leading to higher predictive accuracy. AVAILABILITY AND IMPLEMENTATION: The project code is available at https://github.com/baigeHUI/MethyNano and https://doi.org/10.5281/zenodo.19858400.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.